Abstract:Diabetes mellitus (DM) is a serious chronic disease characterized by abnormally high blood glucose (Glu) levels, which can cause organ malfunction and metabolic disturbances. However, traditional biomarkers like Glu face limitations due to intraday fluctuations and inability to detect early stages of DM. To tackle these challenges, this study has introduced a colorimetric-fluorescence dual-mode biosensor utilizing α-glucosidase (α-GAA), which enables early diabetes screening without being influenced by physiological fluctuations in blood glucose levels. Specifically, chitosan-modified copper nanoclusters (Cu NC@CS-Ce3+: AP-CuCC) with exceptional peroxidase (POD) activity and Ce3+-induced aggregate-induced luminescence (AIE) properties have been synthesized. The targeted hydrolysis of the α-GAA substrate, 4-nitrophenyl-α-D-glucopyranoside (pNGP), results in the formation of p-nitrophenol (p-NP) and Glu. While p-NP statically quenches an increase in AP-CuCC fluorescence signal, Glu facilitates the production of H2O2 by glucose oxidase during AP-CuCC POD enzyme reactions, triggering colorimetric changes in the reaction. The detection limits for colorimetric and fluorescence measurements were determined to be 0.03 U/L and 0.02 U/L, respectively. By integrating fluorescence analysis, this method cleverly mitigates the confusing effects of normal blood Glu levels on colorimetric outcomes, allowing for the consideration of abnormal Glu levels as a supplementary diagnostic tool. Compared to relying solely on colorimetry, this dual-mode approach reduces false positive rates by 50% and false negative rates by 25%. Leveraging the sensor's colorimetric and fluorescent capabilities provides a versatile platform for precise and reliable evaluation of aberrant expression markers across various clinical settings.

A three-in-one point-of-care electrochemical sensing platform for accurate monitoring of diabetes

Multi-parameter Biosensor for Diabetes Monitoring

Smartphone-based Portable Photoelectrochemical Biosensing System for Point-of-care Detection of Urine Creatinine and Albumin

High Accuracy Determination of Multi Metabolite by an Origami-Based Coulometric Electrochemical Biosensor

Smartphone-based integrated voltammetry system for simultaneous detection of ascorbic acid, dopamine, and uric acid with graphene and gold nanoparticles modified screen-printed electrodes

Wireless Non-Enzymatic Glucose Sensing System with Pt-Ni Nanocomposite and Silica Nanoporous Membrane Modified Electrodes for Different Disease Monitoring

Review of point-of-care platforms for diabetes: (1) sensing

Dual-Mode Sensing Chips for Wide-Range and High-Accuracy Biomarker Detection

A novel electrochemical microneedle sensor for highly sensitive real time monitoring of glucose

Multi-parameter detection of diabetes mellitus on multichannel poly(dimethylsiloxane) analytical chips coupled with nanoband microelectrode arrays

AIE multifunctional probe empowering colorimetric-fluorescence dual-mode biosensor for early diabetic screening

Designing Nanocomposite-Based Electrochemical Biosensors for Diabetes Mellitus Detection: A Review

Cobalt metal-organic framework modified carbon cloth/paper hybrid electrochemical button-sensor for nonenzymatic glucose diagnostics

The Impact of Recent Developments in Electrochemical POC Sensor for Blood Sugar Care

Liquid-colloid-solid modular assembly for three-dimensional electrochemical biosensing of small molecules

Electrode surface roughness greatly enhances the sensitivity of electrochemical non-enzymatic glucose sensors

Aptamer-based Biosensors: Promising Sensing Technology for Diabetes Diagnosis in Biological Fluids

Liquid Metal Ink Enabled Rapid Prototyping of Electrochemical Sensor for Wireless Glucose Detection on the Platform of Mobile Phone

Recent Advances on Electrochemical Biosensing Strategies toward Universal Point‐of‐Care Systems

A multi-unit integrated electrochemical biosensor array for synergistic signal enhancing carbohydrate antigen 125 detection

Simultaneous and Rapid Detection of Glucose and Insulin: Coupling Enzymatic and Aptamer-Based Assays